why choose us

First received: April 29, 2024

Clinical Trial: A Dose Finding Study of Debio 4228 in Participants With Advanced Prostate Cancer

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Prostate Cancer

Study Type: INTERVENTIONAL


Official Title: A Phase 2, Randomized, Open-Label, Dose-Finding Study of Debio 4228, an Extended-Release Formulation of Gonadotropin-Releasing Hormone Antagonist in Participants With Advanced Prostate Cancer

Brief Summary: The primary purpose of this study is to determine the pharmacokinetics (PK) and pharmacodynamics (PD) of Debio 4228.

Read more